ZVRA Zevra Therapeutics, Inc. Net earnings per share for the last 12 months

ZVRA (Zevra Therapeutics Inc) - company brandmark

Zevra Therapeutics (ZVRA) trailing 12-month profit per unit demonstrates the company's transition toward stable commercial revenues in the US. The business relies on the market launch of orphan drugs and a diversified pipeline. The integration of scientific platforms with patient support creates a closed-loop cycle for neurological disorder therapy. Consequently, 1.19 becomes the new value for this metric, confirming current financial efficiency.

ZVRA Zevra Therapeutics Earnings per share for the trailing year (04/28/2023 - 11/17/2026)

Zevra Corp - analytical breakdowns and key metrics (ZVRA)

- stock price and consensus target price:
Basic company analysis:zevra.com (ZVRA)
Mass-produced product of Kempharm

Trailing twelve-month earnings per share measures the owner's share of net income adjusted for the total volume of issuance, allowing for an objective assessment of business capitalization efficiency. By analyzing the trailing twelve-month earnings per share trend, an investor can diagnose the financial stability of Zevra Therapeutics (ZVRA), whose profitability is protected by exclusive FDA orphan drug rights and patent barriers.

Analysis of competing companies

Jazz Pharmaceuticals Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytokinetics Inc|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Contineum Corp - Earnings per share for the last twelve months|LRMR - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months capricor.com|TRDA: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Channel PTHS|Net earnings per share for the last 12 months MNOV|Serina (SER) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BTAI|PMN (ProMIS Neurosciences Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Apimeds Pharmaceuticals, Inc. APUS|AEON Biopharma (AEON) - Net earnings per one share for the last twelve months|NLSP - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Bionomics|HUGE (FSD Pharma) - Net earnings per share for the last 12 months|RETA: Earnings per share for the last four quarters